{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":6452,"total_is_capped":false,"direct_labels_cover":21,"predictions_cover":6452,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"d7a97d274c1d","filters":{"topic":"Inflammatory Bowel Disease"}},"results":[{"id":"W2766046358","doi":"10.1016/s0140-6736(17)32448-0","title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","year":2017,"lang":"en","type":"review","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5927,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario; University of Ottawa; University of Calgary","funders":"","keywords":"Ulcerative colitis; Medicine; Inflammatory bowel disease; Incidence (geometry); Population; Disease; Internal medicine; Crohn's disease; Epidemiology; Systematic review; MEDLINE; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.03972378559779149,"gpt":0.3409515483944233,"spread":0.3012277627966318,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017073,0.0002762112,0.001413478,0.00004466977,0.00007344428,0.00001644402,0.001090321,0.00007544074,0.000002551817],"category_scores_gemma":[0.002580478,0.0001461673,0.0002533979,0.0000625594,0.0002291119,0.000006209582,0.0001856365,0.000144583,0.000001900142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002261705,"about_ca_system_score_gemma":0.000242674,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006611185,"about_ca_topic_score_gemma":0.00002270477,"domain_scores_codex":[0.9974933,0.0009691967,0.0008194215,0.0002691949,0.000269322,0.0001795675],"domain_scores_gemma":[0.996456,0.0002007903,0.001298012,0.001893365,0.0001076431,0.00004414245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00002625072,0.00001509644,0.003584684,0.9951343,0.00009632821,0.00001447447,0.00003297209,0.000002159536,5.960908e-7,0.0001279756,0.000118249,0.0008468898],"study_design_scores_gemma":[0.0002238268,0.00001770959,0.02013428,0.9649455,0.002117026,0.000004423771,0.00003223421,0.000004805295,7.808171e-7,0.00004081952,0.01223228,0.0002463215],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001326897,0.9961057,3.544125e-7,0.00007457763,0.00005273671,0.002203911,0.0001873896,0.000004211551,0.00004424606],"genre_scores_gemma":[0.006334199,0.992785,0.00001121766,0.000216981,0.0001221029,0.000409219,0.00007238388,0.0000192614,0.00002964492],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03018883,"threshold_uncertainty_score":0.5960528,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143625465","doi":"10.1038/nature11582","title":"Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease","year":2012,"lang":"en","type":"review","venue":"Nature","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4859,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; Université de Montréal; University of Toronto; Royal Victoria Hospital; Montreal Heart Institute","funders":"National Cancer Institute; Helmholtz Zentrum München; National Health and Medical Research Council; Inflammatory Bowel and Immunobiology Research Institute; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; Versus Arthritis; National Institutes of Health; Svenska Läkaresällskapet; Karolinska Institutet; Crohn's and Colitis UK; Ministero della Salute; Diabetes UK; Fonds Wetenschappelijk Onderzoek; U.S. Public Health Service; National Human Genome Research Institute; Fonds De La Recherche Scientifique - FNRS; National Institute for Health and Care Research; Bundesministerium für Bildung und Forschung; Cedars-Sinai Medical Center; Deutsche Forschungsgemeinschaft; Universitetssjukhuset Örebro; King's College London; Crohn's and Colitis Foundation of America; National Institute of General Medical Sciences; Crohn's and Colitis Foundation; Münchner Zentrum für Gesundheitswissenschaften; Exzellenzclusters Entzündungsforschung; British Heart Foundation; Wellcome Trust; National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; Örebro Universitet; National Center for Advancing Translational Sciences; Medical Research Council; Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Inflammatory bowel disease; Host (biology); Disease; Inflammatory Bowel Diseases; Genetic architecture; Biology; Medicine; Genetics; Pathology; Gene; Phenotype","retraction":null,"screen_n_in":null,"score":{"opus":0.01010341872798213,"gpt":0.2817340420049009,"spread":0.2716306232769187,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0001641663,0.0005750956,0.0005305714,0.0001220791,0.0001267614,0.00003319707,0.0008237943,0.001728434,0.0001142045],"category_scores_gemma":[0.0001641193,0.0003907673,0.000922523,0.00009019423,0.000205721,0.00000526853,0.0003776283,0.002564319,0.00004921688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004370754,"about_ca_system_score_gemma":0.0005619834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000137333,"about_ca_topic_score_gemma":0.00003031153,"domain_scores_codex":[0.9979527,0.0003224202,0.0005426844,0.0005111665,0.0002603897,0.0004106406],"domain_scores_gemma":[0.9977303,0.00004760144,0.0005041083,0.001291548,0.0001494091,0.0002770087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001303522,0.001079805,0.004529292,0.1008954,0.005382049,0.0009380438,0.0006227629,0.0001023019,0.005658772,0.0006418892,0.04592533,0.8329208],"study_design_scores_gemma":[0.0001584124,0.00001335828,0.004967516,0.001191266,0.001222669,0.00004644294,0.00001008483,0.000002673185,0.00003046152,0.00001620849,0.991923,0.0004179061],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001482845,0.9958489,0.00003274978,0.00005687982,0.0006358406,0.001006685,0.0005870884,0.00002140894,0.0003276008],"genre_scores_gemma":[0.004919592,0.9902213,0.0001309924,0.0004421007,0.001705131,0.0002243266,0.0008802665,0.0001487601,0.001327545],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9459977,"threshold_uncertainty_score":0.9998544,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2004608617","doi":"10.1053/j.gastro.2011.10.001","title":"Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review","year":2011,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4818,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Crohn's and Colitis Foundation","keywords":"Incidence (geometry); Medicine; Demography; Inflammatory bowel disease; Population; Ulcerative colitis; Inflammatory Bowel Diseases; Epidemiology; Disease; Environmental health; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.006968394080446092,"gpt":0.2299482022199384,"spread":0.2229798081394923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004502483,0.0004556682,0.001163147,0.00007144022,0.00006131968,0.000008970341,0.0006352419,0.0001743404,0.00002411609],"category_scores_gemma":[0.0004249357,0.0002753154,0.0003275644,0.00005491654,0.0003897156,0.000005223058,0.0002681665,0.0001863739,0.00001222099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002595871,"about_ca_system_score_gemma":0.000253398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001555493,"about_ca_topic_score_gemma":0.000005907592,"domain_scores_codex":[0.9967065,0.001567224,0.0007049096,0.0005227005,0.0001888263,0.0003098738],"domain_scores_gemma":[0.9975287,0.00006116391,0.000966347,0.001213836,0.00009803018,0.0001318948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002825839,0.00005740991,0.01358725,0.9854478,0.0001702143,0.00003431759,0.000003496448,0.000001973511,0.000006192534,0.000005849275,0.0001276204,0.0002753443],"study_design_scores_gemma":[0.0006247018,0.0008678226,0.02003896,0.9660051,0.008133908,0.000506815,0.000002079565,0.00002025653,0.000004012601,0.000003368634,0.003346811,0.0004461688],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006595894,0.9909143,0.00001814447,0.000008356131,0.00005151792,0.00219779,0.0001589137,0.00001280926,0.00004231276],"genre_scores_gemma":[0.002110703,0.9966397,0.00005995028,0.0005768382,0.00004365025,0.0003868222,0.00005254802,0.00005680324,0.00007303688],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01944265,"threshold_uncertainty_score":0.9999699,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2171341132","doi":"10.1016/s0140-6736(02)08512-4","title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","year":2002,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4163,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Infliximab; Crohn's disease; Placebo; Internal medicine; Clinical endpoint; Odds ratio; Randomized controlled trial; Surgery; Gastroenterology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02416861364760068,"gpt":0.261955837085911,"spread":0.2377872234383103,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000336118,0.0001248321,0.0001508123,0.000006992628,0.0001770604,0.00004973655,0.0005223837,0.00004380583,0.00008265769],"category_scores_gemma":[0.0004052859,0.00006666556,0.0001697514,0.00003061357,0.000118454,0.000002963181,0.00007952371,0.00006846114,0.00003162783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001050119,"about_ca_system_score_gemma":0.00002995181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001174325,"about_ca_topic_score_gemma":0.000005586767,"domain_scores_codex":[0.9991229,0.000108043,0.0001596218,0.0001954442,0.0001105563,0.0003034819],"domain_scores_gemma":[0.9989774,0.0000465883,0.00007985809,0.0007744635,0.00005123105,0.00007047471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.3975351,0.0001532642,0.0003963945,0.00006152847,0.0001661634,0.00005478204,0.0001370022,0.0001854979,0.002723202,0.001988329,0.5933858,0.00321291],"study_design_scores_gemma":[0.3014289,0.00009794277,0.02885307,0.00001926198,0.0001197214,0.000003329394,0.0000332477,0.001435375,0.000883246,0.0009434838,0.665868,0.000314351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799984,0.001367268,0.0007211157,0.009232713,0.0006640118,0.003413543,0.0002205679,0.00004438162,0.004338053],"genre_scores_gemma":[0.9894405,0.0002221552,0.00006051394,0.003182259,0.003202029,0.0006613216,0.00003947315,0.00002410357,0.003167651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09610617,"threshold_uncertainty_score":0.2718543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2171297959","doi":"10.1056/nejmoa050516","title":"Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis","year":2005,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3883,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Infliximab; Medicine; Ulcerative colitis; Placebo; Internal medicine; Gastroenterology; Maintenance therapy; Surgery; Inflammatory bowel disease; Tumor necrosis factor alpha; Chemotherapy; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01243505316750828,"gpt":0.2730584379347014,"spread":0.2606233847671932,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003808222,0.00007627087,0.0001256647,0.00003371158,0.00003930461,0.000005663728,0.00005032668,0.00004949548,0.00001092274],"category_scores_gemma":[0.0002459151,0.00005274409,0.00003870756,0.00001586982,0.00007830476,0.000007277054,0.000005666958,0.00005126122,1.443047e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001223926,"about_ca_system_score_gemma":0.00009246878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002802929,"about_ca_topic_score_gemma":0.00004349862,"domain_scores_codex":[0.9995041,0.00002709382,0.0002037083,0.00008426658,0.00007468682,0.0001061079],"domain_scores_gemma":[0.9994285,0.00002931765,0.0001475087,0.00006153153,0.0002239285,0.0001091993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02769536,0.0000811615,0.001859905,0.00005807137,0.0002605073,0.00002344746,0.00127744,0.0001294091,0.09397098,0.001376032,0.0850463,0.7882214],"study_design_scores_gemma":[0.1038752,0.003364497,0.03523789,0.0001015705,0.00006136926,0.00034568,0.0002810829,0.0001368718,0.01436877,0.001491139,0.8405747,0.0001612873],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838263,0.0009524357,0.008930343,0.005597835,0.0002558409,0.0002958374,0.00001082745,0.00000213765,0.0001284561],"genre_scores_gemma":[0.9881605,0.0007021899,0.002198395,0.0009374256,0.00747487,0.00001027316,0.00001399385,0.00001163025,0.0004907017],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7880601,"threshold_uncertainty_score":0.2150842,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2188248802","doi":"10.1155/2005/269076","title":"Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","year":2005,"lang":"en","type":"article","venue":"Canadian Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3392,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true},"ca_institutions":"University of Toronto; University of Manitoba; Mount Sinai Hospital","funders":"","keywords":"Inflammatory bowel disease; Serology; Ulcerative colitis; Disease; Clinical phenotype; Medicine; Internal medicine; Immunology; Phenotype; Biology; Antibody; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02314745398006342,"gpt":0.2588309344290198,"spread":0.2356834804489564,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009474434,0.0002084854,0.0005612462,0.0002264073,0.00003406566,0.000006285137,0.0004892411,0.0001827354,0.00002961082],"category_scores_gemma":[0.0003207432,0.0001688303,0.0002980786,0.00006687832,0.001278907,0.00001804191,0.00007495197,0.0002857372,1.591008e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003511126,"about_ca_system_score_gemma":0.0007174903,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000106267,"about_ca_topic_score_gemma":0.03030046,"domain_scores_codex":[0.9967545,0.000760722,0.001624972,0.0002819821,0.0001783364,0.0003995173],"domain_scores_gemma":[0.9964403,0.00002258423,0.001937168,0.0005066321,0.0004978424,0.0005955113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004085938,0.0001361251,0.9788033,0.00005261517,0.000236318,0.0002942665,0.0000419508,0.0006377843,0.01475312,0.0000481644,0.0007128114,0.000197624],"study_design_scores_gemma":[0.001647241,0.001132512,0.9938046,0.00009414503,0.0001714283,0.0002825216,0.00008073387,0.0001968904,0.001694735,0.00003089218,0.0007934725,0.00007087745],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982828,0.0001993967,0.0002866527,0.0006783967,0.0002422211,0.0001950467,0.0000835485,0.00000195191,0.00002995816],"genre_scores_gemma":[0.9991181,0.00004482664,0.0003843991,0.0002641987,0.0001074593,0.00000528982,0.00003149263,0.00001918536,0.0000250597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03019419,"threshold_uncertainty_score":0.987394,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085284704","doi":"10.1016/j.chom.2014.02.005","title":"The Treatment-Naive Microbiome in New-Onset Crohn’s Disease","year":2014,"lang":"en","type":"article","venue":"Cell Host & Microbe","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3298,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's Hospital of Eastern Ontario; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Human Genome Research Institute; National Institute of General Medical Sciences; Crohn's and Colitis Foundation","keywords":"Biology; Microbiome; Disease; Crohn's disease; Gut microbiome; Computational biology; Bioinformatics; Immunology; Internal medicine; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.004041871243028615,"gpt":0.2098298668376804,"spread":0.2057879955946518,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001157083,0.0002488327,0.000124341,0.00004352193,0.0001584095,0.00006740609,0.0003112207,0.0001049542,0.00003878913],"category_scores_gemma":[0.000038787,0.0001952611,0.000154337,0.00007030894,0.0001377798,0.000004157928,0.00009330866,0.00006927374,0.0002613684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006190311,"about_ca_system_score_gemma":0.0002784601,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005133368,"about_ca_topic_score_gemma":0.0002885121,"domain_scores_codex":[0.9987583,0.0001193902,0.0002212045,0.0004160304,0.00005970132,0.0004253994],"domain_scores_gemma":[0.9989234,0.0000235056,0.00007755651,0.0006764747,0.00003862295,0.0002604862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000765955,0.0002971472,0.03773561,0.00002867714,0.00003694071,0.0001343283,0.0001680568,0.00002069505,0.9274693,0.0000362656,0.03175614,0.001550909],"study_design_scores_gemma":[0.002010547,0.0001165327,0.3191999,0.00001717016,0.00004526718,0.000005809768,0.00005359287,0.00002115156,0.1600094,0.00005790519,0.5180715,0.0003912462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968826,0.001377294,0.00005925592,0.0002010953,0.0002260474,0.0003555189,0.00008669282,0.00001696029,0.0007945376],"genre_scores_gemma":[0.985255,0.0003780915,0.0001028323,0.0005507942,0.0002453629,0.00003120926,0.000248665,0.00004491243,0.01314314],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7674599,"threshold_uncertainty_score":0.7962517,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102013054","doi":"10.1136/gut.2005.082909","title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","year":2006,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3156,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"University of Toronto; University of Oxford","keywords":"Inflammatory bowel disease; Disease; Medicine; Relevance (law); Inflammatory Bowel Diseases; Political science; Intensive care medicine; Pathology; Law","retraction":null,"screen_n_in":null,"score":{"opus":0.005116474841808607,"gpt":0.2164095661965212,"spread":0.2112930913547126,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008732046,0.00007658453,0.00004809866,0.00001374684,0.0001326691,0.00001607346,0.00009185022,0.00004729762,0.000002018691],"category_scores_gemma":[0.00009758909,0.00006372072,0.00004125101,0.00001892445,0.0002234934,0.000001991572,0.00003886033,0.00002888626,0.000003756891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009372375,"about_ca_system_score_gemma":0.0001008142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002810157,"about_ca_topic_score_gemma":0.0002230993,"domain_scores_codex":[0.999449,0.00004134067,0.0001679561,0.0001531338,0.00006722048,0.0001214208],"domain_scores_gemma":[0.9993656,0.00003916591,0.00009884694,0.0003415476,0.00009035234,0.00006448816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006212362,0.00008312181,0.5084097,0.0000596655,0.00007593715,0.0000111124,0.00002237435,0.0000865546,0.3868853,0.04224908,0.05940723,0.002088701],"study_design_scores_gemma":[0.0003587567,0.000008995675,0.97651,0.000003311057,0.00002414903,0.000001617368,0.00002863264,0.0001155974,0.0005350618,0.000819046,0.02152286,0.00007190448],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995245,0.001202307,0.00006673529,0.0007701226,0.00003878946,0.0002077331,0.0001134875,0.00001147749,0.002344332],"genre_scores_gemma":[0.998965,0.0000910395,0.00002795207,0.0000605368,0.00009532407,0.00003177519,0.0001083331,0.000008975298,0.000611061],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4681003,"threshold_uncertainty_score":0.2598456,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162805528","doi":"10.1056/nejmoa1215734","title":"Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2852,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Robarts Clinical Trials; Western University","funders":"Takeda Pharmaceuticals International","keywords":"Vedolizumab; Ulcerative colitis; Induction therapy; Maintenance therapy; Medicine; Internal medicine; Disease; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01002959855712218,"gpt":0.2578046912679587,"spread":0.2477750927108366,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002322388,0.00007948861,0.0001226934,0.00003364936,0.00003673905,0.000009101128,0.00005676114,0.00005050439,0.0000745864],"category_scores_gemma":[0.0002400402,0.00005270812,0.00003028218,0.00001949477,0.00007520965,0.000008452784,0.000008240377,0.0000696985,0.000001602131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009736264,"about_ca_system_score_gemma":0.0001038384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002857471,"about_ca_topic_score_gemma":0.00001660999,"domain_scores_codex":[0.9994763,0.00004750978,0.0001877831,0.0000853667,0.00009602279,0.0001069952],"domain_scores_gemma":[0.9993691,0.00001998894,0.0001386621,0.00007339349,0.0002491156,0.0001497126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01139311,0.00007434806,0.004137139,0.00004972011,0.0003082727,0.0001171187,0.001532793,0.00002264544,0.2039013,0.001125904,0.1368521,0.6404856],"study_design_scores_gemma":[0.1275469,0.007750185,0.4926071,0.0002580691,0.00008815456,0.001968331,0.0009643094,0.00005961648,0.01821514,0.01225536,0.3379393,0.0003475816],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951207,0.000568056,0.0007827477,0.002606671,0.0002883153,0.0002082336,0.000002074985,0.000001837258,0.0004213601],"genre_scores_gemma":[0.9942746,0.0008143475,0.0002970379,0.0007229723,0.003207094,0.000007119214,0.000007069495,0.000009651142,0.0006600786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.640138,"threshold_uncertainty_score":0.2149375,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2077531651","doi":"10.1056/nejmoa1215739","title":"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2687,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of Alberta; Western University","funders":"Takeda Pharmaceuticals International","keywords":"Vedolizumab; Maintenance therapy; Crohn's disease; Induction therapy; Medicine; Disease; Intensive care medicine; Internal medicine; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.009415306880829078,"gpt":0.2526207967930719,"spread":0.2432054899122428,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002114622,0.00008992373,0.0001164431,0.0000399276,0.00003728293,0.00001032,0.00007526026,0.00004155023,0.00006815711],"category_scores_gemma":[0.0003344014,0.00005895374,0.00004138151,0.00002073107,0.00007608218,0.000009409852,0.00001123276,0.00006852105,0.000002028409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007808296,"about_ca_system_score_gemma":0.0001274727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001549863,"about_ca_topic_score_gemma":0.000003103535,"domain_scores_codex":[0.9994337,0.0000357311,0.0001965944,0.00009947645,0.0001154464,0.0001190298],"domain_scores_gemma":[0.9992481,0.00001603607,0.0001398803,0.0001075991,0.0001961571,0.0002922482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01561285,0.00012665,0.01497144,0.00009646346,0.0002527387,0.0005284364,0.0005357555,0.00004956539,0.1745006,0.0005872665,0.1411695,0.6515687],"study_design_scores_gemma":[0.06218271,0.001793778,0.7343103,0.0001598635,0.00008235065,0.0004440822,0.0001767875,0.00004770403,0.002063418,0.006930263,0.1915914,0.0002173445],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935843,0.001660593,0.0006946669,0.003386199,0.0003241946,0.0002034146,0.000002058362,0.000002465303,0.000142087],"genre_scores_gemma":[0.9938468,0.0009298875,0.0002043915,0.0008318641,0.003573054,0.000006826578,0.000008378557,0.00001224662,0.0005865994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7193388,"threshold_uncertainty_score":0.2404064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3115410759","doi":"10.1053/j.gastro.2020.12.031","title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD","year":2021,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2666,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"Celgene; Biogen; Janssen Pharmaceuticals; Gilead Sciences; Medtronic; Amgen; Pfizer; Shire; Bristol-Myers Squibb; Roche; Meso Scale Diagnostics; Takeda Pharmaceutical Company; AbbVie; Merck","keywords":"STRIDE; Medicine; Physical medicine and rehabilitation; Disease; Inflammatory bowel disease; Intensive care medicine; Physical therapy; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02900265889026595,"gpt":0.3059937723607599,"spread":0.276991113470494,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000763876,0.0004425884,0.0006746041,0.0001820372,0.00017715,0.00005041192,0.001030946,0.0001772207,0.0000161801],"category_scores_gemma":[0.0004209925,0.000276032,0.0002867965,0.0002037546,0.0001277139,0.00002154663,0.0003037499,0.0002729491,4.398611e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009571301,"about_ca_system_score_gemma":0.0005845217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005576739,"about_ca_topic_score_gemma":0.0003725125,"domain_scores_codex":[0.9967874,0.0009921809,0.0009863571,0.000594668,0.0002183001,0.0004211236],"domain_scores_gemma":[0.9978298,0.0002840082,0.0008073336,0.0006971747,0.0003163443,0.00006534479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01991719,0.0111345,0.7479684,0.0118305,0.01246841,0.0003781898,0.01858369,0.03888875,0.00610559,0.005214693,0.0009074882,0.1266026],"study_design_scores_gemma":[0.03766078,0.02450395,0.7883894,0.01342438,0.0100782,0.00021689,0.04487951,0.006185364,0.004718687,0.003166469,0.06215469,0.004621654],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.923162,0.0680275,0.00120996,0.0002885623,0.0004496941,0.006315019,0.0005234362,0.00001384675,0.000009939995],"genre_scores_gemma":[0.9771589,0.02037425,0.00005773351,0.0005771272,0.00018149,0.001094867,0.0004440579,0.0001011465,0.00001039502],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.121981,"threshold_uncertainty_score":0.9999692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165872127","doi":"10.1038/ng.175","title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease","year":2008,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2628,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; McGill University; Mount Sinai Hospital; SickKids Foundation; Royal Victoria Hospital; University of Toronto; Université de Montréal; Montreal Heart Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Wellcome Trust","keywords":"Biology; Genome-wide association study; Disease; Genetics; Genome; Genetic association; Crohn's disease; Single-nucleotide polymorphism; Gene; Genotype; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0123695905525591,"gpt":0.2866665089245244,"spread":0.2742969183719653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002528505,0.0007825455,0.0009052044,0.00008686452,0.0002386007,0.00006243541,0.0006571637,0.001939637,0.0000304649],"category_scores_gemma":[0.002049946,0.0007286077,0.00122829,0.0001435971,0.000121267,0.000003770932,0.0002623338,0.0006222812,0.00003898421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002991902,"about_ca_system_score_gemma":0.001056729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001061444,"about_ca_topic_score_gemma":0.00003480268,"domain_scores_codex":[0.9968843,0.0002077279,0.0006933351,0.0011126,0.0004456982,0.0006563588],"domain_scores_gemma":[0.9970449,0.0001242275,0.0006662766,0.001249213,0.0005133293,0.0004020168],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001717198,0.001934542,0.3846983,0.09945031,0.005493539,0.00218125,0.0002045887,0.0002093233,0.00009335084,0.00007746632,0.1754452,0.3284949],"study_design_scores_gemma":[0.0003203823,0.00003776787,0.1710609,0.0002187921,0.00074713,0.000004083984,0.000002712714,0.000004483878,0.00000671161,0.00005019064,0.8268707,0.0006761886],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01896345,0.975476,0.0001209633,0.00004306672,0.0005367075,0.002095765,0.002612371,0.00004603362,0.0001056292],"genre_scores_gemma":[0.003116908,0.982361,0.0004669098,0.0002967014,0.001888602,0.0003481903,0.01016051,0.0001838543,0.001177364],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6514254,"threshold_uncertainty_score":0.9995165,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2182578492","doi":"10.1038/nrgastro.2015.150","title":"The global burden of IBD: from 2015 to 2025","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Gastroenterology & Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2624,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Epidemiology; Developed country; Global health; Incidence (geometry); Health care; Disease; Quality of life (healthcare); Environmental health; Developing country; Gerontology; Economic growth; Public health; Population; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01881775669986504,"gpt":0.3455580215239372,"spread":0.3267402648240721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001101645,0.0008942471,0.003153358,0.00009820989,0.0001014207,0.0000208078,0.001872396,0.00217912,0.00004243061],"category_scores_gemma":[0.0007517567,0.0006062217,0.001188711,0.0002181064,0.0003927876,0.000004618208,0.000924262,0.001040421,0.0003365319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001820188,"about_ca_system_score_gemma":0.0007444047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003497839,"about_ca_topic_score_gemma":0.0007358301,"domain_scores_codex":[0.9936273,0.002379226,0.001669689,0.001149712,0.0002716343,0.0009024744],"domain_scores_gemma":[0.99597,0.00006812109,0.001181984,0.001996769,0.0003463822,0.0004367535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001144248,0.000129441,0.005684307,0.004109475,0.001645988,0.0002896087,0.00002541944,0.000002452955,0.00001433596,0.0002803657,0.3698203,0.616854],"study_design_scores_gemma":[0.0003852221,0.0003241376,0.000106503,0.0009520483,0.00101461,0.0001601357,0.00000526546,0.000001073897,0.000001097994,0.00008387445,0.9966956,0.0002703718],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008864729,0.9940441,0.00005607103,0.0003672443,0.001638932,0.00195447,0.0008159458,0.00001866132,0.0002180672],"genre_scores_gemma":[0.0001020686,0.995643,0.0003999043,0.001118813,0.0009333378,0.0004345508,0.001141224,0.00006695065,0.0001601546],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6268753,"threshold_uncertainty_score":0.9996389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106779017","doi":"10.1038/ng.717","title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci","year":2010,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2581,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute; Hospital for Sick Children; University of Toronto; SickKids Foundation; Mount Sinai Hospital; Jewish General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Health and Medical Research Council; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; National Institutes of Health; Exzellenzclusters Entzündungsforschung; Fonds De La Recherche Scientifique - FNRS; Cedars-Sinai Medical Center; Deutsche Forschungsgemeinschaft; King's College London; National Institute for Health and Care Research; Action Medical Research; National Center for Research Resources; Fonds Wetenschappelijk Onderzoek; Crohn's and Colitis Foundation; Wellcome Trust; Abbott Laboratories; Crohn's and Colitis Foundation of America","keywords":"Biology; Genome-wide association study; Genetics; Genome; In silico; Genetic association; Disease; Gene; Crohn's disease; Single-nucleotide polymorphism; Genotype","retraction":null,"screen_n_in":null,"score":{"opus":0.02281885005735509,"gpt":0.3255244616539011,"spread":0.302705611596546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006655627,0.0008070579,0.002194672,0.0001461175,0.0001303635,0.00006257143,0.001402495,0.001420792,0.0006839001],"category_scores_gemma":[0.001021225,0.00053319,0.004565135,0.0005829731,0.0003441455,0.000002621906,0.0005810827,0.0009966895,0.00006865466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000373301,"about_ca_system_score_gemma":0.000896612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001187293,"about_ca_topic_score_gemma":0.0002835845,"domain_scores_codex":[0.9962206,0.0006307301,0.0009646809,0.001108782,0.0005789566,0.0004962037],"domain_scores_gemma":[0.9948438,0.0001386154,0.0006341431,0.003208624,0.000591175,0.000583673],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001879976,0.002783132,0.04587701,0.03647872,0.7986569,0.001836664,0.0002048636,0.0007241175,0.0005714186,0.0002823019,0.01700399,0.09370095],"study_design_scores_gemma":[0.0001046278,0.0000149109,0.03042644,0.00002333166,0.2247652,0.000003925155,0.000004338103,0.000001094447,0.0000325033,0.00002615304,0.7441025,0.0004949921],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02293229,0.9726468,0.00005615769,0.00004443192,0.0001534722,0.001603723,0.002315076,0.00001702715,0.00023104],"genre_scores_gemma":[0.03367618,0.9593062,0.000738761,0.00091076,0.0006277653,0.000346859,0.003248309,0.000149867,0.0009952679],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7270985,"threshold_uncertainty_score":0.9998755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2981768636","doi":"10.1016/s2468-1253(19)30333-4","title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017","year":2019,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2264,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Division of Gastroenterology and Hepatology, School of Medicine, Indiana University; National Cancer Institute; Fuel Cell Technologies Program; UCLH Biomedical Research Centre; Department of Medicine, Georgetown University; Department of Chemistry, University of York; Medical Research Council; Department of Psychology, Western Washington University; School of Medicine; School of Medicine and Public Health, University of Wisconsin-Madison; Adigrat University; Jahrom University of Medical Sciences; Applied Molecular Biosciences Unit; Universiti Sultan Zainal Abidin; Lorestan University of Medical Sciences; University of Hail; Department of Radiology, Weill Cornell Medical College; Zanjan University of Medical Sciences; Wuhan University; Trường Đại học Duy Tân; Ministério da Ciência, Tecnologia e Ensino Superior; Universidade do Porto; Shahid Beheshti University of Medical Sciences; Public Health England; Universität Bielefeld; Guilan University of Medical Sciences; Università di Catania; Shiraz University of Medical Sciences; Public Health Institute; Massachusetts General Hospital; University of Cape Town; Babol Noshirvani University of Technology; Kashan University of Medical Sciences; Hamad Bin Khalifa University; University of Toronto; Iran University of Medical Sciences; Amirkabir University of Technology; Sharif University of Technology; University of Melbourne; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Tabriz University of Medical Sciences; Khalifa University of Science, Technology and Research; University of Technology Sydney; Kermanshah University of Medical Sciences; Institute for Health Metrics and Evaluation; Department of Science and Technology, Ministry of Science and Technology, India; Addis Ababa University; Helsingin ja Uudenmaan Sairaanhoitopiiri; University of Birmingham; Salahaddin University-Erbil; Public Health Agency of Canada; Trường Đại học Y Hà Nội; Utica College; Islamic Azad University; Maragheh University of Medical Sciences; Trường Đại học Nguyễn Tất Thành; University of Louisiana at Lafayette; Queen Elizabeth Hospital Birmingham Charity; McGill University; Razi Herbal Medicines Research Center; King Saud University; College of Medicine, University of Florida; University of Ibadan; Fundação para a Ciência e a Tecnologia; Department of Biology, University of New Mexico; University of Washington; Bill and Melinda Gates Foundation; Urmia University of Medical Sciences; Johns Hopkins University; University of Alabama; College of Science and Engineering, University of Minnesota; Babol University of Medical Sciences; Mazandaran University of Medical Sciences","keywords":"Medicine; Disease burden; Population; Years of potential life lost; Burden of disease; Demography; Mortality rate; Disability-adjusted life year; Inflammatory bowel disease; Quality-adjusted life year; Epidemiology; Disease; Life expectancy; Environmental health; Cost effectiveness; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01100923742360905,"gpt":0.2621685785892836,"spread":0.2511593411656746,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009372644,0.0002940269,0.0006692981,0.00006455174,0.0002103993,0.0000364104,0.0006998732,0.0001220053,0.000003112712],"category_scores_gemma":[0.0002157647,0.0001879784,0.0001933744,0.000108579,0.001075311,0.00001579685,0.0003447484,0.000116071,0.000001535513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007011074,"about_ca_system_score_gemma":0.0002797482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003080791,"about_ca_topic_score_gemma":0.004495982,"domain_scores_codex":[0.9973305,0.0006551121,0.0007063993,0.000513161,0.0003123237,0.0004824571],"domain_scores_gemma":[0.99786,0.0002466362,0.0005474521,0.0009088835,0.0002851014,0.0001519811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006077862,0.00007490721,0.9894041,0.0008828122,0.001223688,0.00002701263,0.0001412093,0.0005847686,0.00002968737,0.0008670583,0.0006828575,0.000003971777],"study_design_scores_gemma":[0.002581953,0.000352383,0.9890279,0.00008570445,0.001024109,0.0000231804,0.0005801271,0.004442464,0.000001223776,0.0006217959,0.001124703,0.0001344239],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923018,0.003098633,0.00008987648,0.001895171,0.0002331543,0.001661405,0.0006989528,0.000008991012,0.00001198812],"genre_scores_gemma":[0.9984951,0.0003259477,0.000016034,0.0004122077,0.0002362104,0.0003907975,0.00008867429,0.00001275751,0.00002228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006193263,"threshold_uncertainty_score":0.7665535,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991810959","doi":"10.1053/j.gastro.2006.11.041","title":"Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial","year":2006,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2250,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Adalimumab; Medicine; Placebo; Internal medicine; Crohn's disease; Adverse effect; Randomized controlled trial; Gastroenterology; Tumor necrosis factor alpha; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.00775839641657307,"gpt":0.2611711406707846,"spread":0.2534127442542116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004957984,0.0001002209,0.00015531,0.00002462361,0.00003079123,0.000004223036,0.0001138481,0.00006698249,0.000003326031],"category_scores_gemma":[0.0002266888,0.0000670614,0.00006519342,0.00001689059,0.0001976628,0.00000263441,0.00006107486,0.00006026942,2.931978e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006887376,"about_ca_system_score_gemma":0.00005612254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004293717,"about_ca_topic_score_gemma":0.00007227852,"domain_scores_codex":[0.9988123,0.000289823,0.0003458379,0.000259797,0.00007432592,0.0002179363],"domain_scores_gemma":[0.9994109,0.00003612889,0.0001565251,0.0002595027,0.00007218778,0.00006474213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4715419,0.0001547182,0.5270326,0.000009451619,0.00001059797,0.00001046676,0.00000338491,0.00001233173,0.000351693,0.000007415389,0.000773732,0.00009178558],"study_design_scores_gemma":[0.04248482,0.001421955,0.9548898,0.00001302411,0.00001833785,8.551394e-7,0.000005400015,0.00003181655,0.00003261044,0.0000300626,0.001027521,0.00004375633],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986285,0.00001975163,0.0001895327,0.0003433289,0.0001016407,0.0006338393,0.00007359586,0.000003140579,0.000006647851],"genre_scores_gemma":[0.9992178,0.000005185412,0.0001834922,0.0002521851,0.0001152289,0.0000679889,0.00006812735,0.00001238036,0.00007757646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4290571,"threshold_uncertainty_score":0.2734684,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026116536","doi":"10.1056/nejmoa030815","title":"Infliximab Maintenance Therapy for Fistulizing Crohn's Disease","year":2004,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2221,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal General Hospital; University of Alberta; Vancouver General Hospital; Health Sciences Centre; Western University; University of Manitoba","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Infliximab; Maintenance therapy; Crohn's disease; Placebo; Surgery; Randomization; Internal medicine; Randomized controlled trial; Gastroenterology; Disease; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01134458852969855,"gpt":0.2630441158727721,"spread":0.2516995273430735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003734907,0.0001242394,0.0001669685,0.00004955532,0.00004889874,0.000008474865,0.0001669818,0.00004355359,0.00002136556],"category_scores_gemma":[0.0004926142,0.00008508704,0.0001022352,0.00003606238,0.0001122588,0.000006628567,0.00001560239,0.00008893249,0.000001213355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002233491,"about_ca_system_score_gemma":0.0003313093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007965198,"about_ca_topic_score_gemma":0.00001259535,"domain_scores_codex":[0.9991848,0.00002933089,0.0003015888,0.0001227762,0.0001803402,0.0001811086],"domain_scores_gemma":[0.9990764,0.00001911261,0.0002036708,0.0001677021,0.0002014306,0.0003317149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1103743,0.0009204036,0.03706603,0.0004328353,0.001199968,0.0116217,0.002741904,0.008265673,0.3029025,0.006767109,0.149049,0.3686585],"study_design_scores_gemma":[0.2332551,0.002469092,0.225334,0.0005655858,0.0001681139,0.0004087656,0.0002217815,0.00003113443,0.006080742,0.009372553,0.5216373,0.0004559014],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980983,0.002835688,0.009479266,0.005743281,0.0004981221,0.0002121309,0.000008504021,0.000005456236,0.0002345825],"genre_scores_gemma":[0.9917414,0.0006370391,0.0008960686,0.001613383,0.004798547,0.00000426284,0.00001545908,0.00001989054,0.0002739223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3725882,"threshold_uncertainty_score":0.3469749,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149170290","doi":"10.1038/ajg.2015.233","title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target","year":2015,"lang":"en","type":"review","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1838,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; University of Calgary; Mount Sinai Hospital; Western University; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Inflammatory bowel disease; STRIDE; Intensive care medicine; Disease; Therapeutic approach; Physical medicine and rehabilitation; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02195626989605284,"gpt":0.3147373358469824,"spread":0.2927810659509296,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001621,0.0006270056,0.001703569,0.0003824917,0.00009813303,0.00004741754,0.001073218,0.0001277922,0.000006857187],"category_scores_gemma":[0.0002278332,0.0004469759,0.0008205746,0.0001615094,0.000327354,0.00001292342,0.000180377,0.0005050341,0.000007446858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001705666,"about_ca_system_score_gemma":0.0009317505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001713732,"about_ca_topic_score_gemma":0.00001512114,"domain_scores_codex":[0.9956445,0.00144062,0.00132407,0.0004736883,0.0002663867,0.0008507096],"domain_scores_gemma":[0.9963983,0.0001379838,0.002075372,0.0006226074,0.0002846452,0.000481054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04837018,0.0005829612,0.05451474,0.003863835,0.00355215,0.002008009,0.0007084901,0.001660625,0.0004867303,0.00002461976,0.001833665,0.882394],"study_design_scores_gemma":[0.006823578,0.02566542,0.02091795,0.004513367,0.005082153,0.003514505,0.0007267511,0.0002291254,0.0000298676,0.000551617,0.9300357,0.001909932],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1235338,0.8714594,0.002642861,0.0002000862,0.0004466477,0.001566649,0.0001178063,0.00001617851,0.00001661939],"genre_scores_gemma":[0.1189703,0.8712953,0.001890333,0.003891125,0.002564412,0.0006031243,0.0001616294,0.0004797188,0.0001441217],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9282021,"threshold_uncertainty_score":0.9997982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233817719","doi":"10.1056/nejmoa1602773","title":"Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1806,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Calgary; Robarts Clinical Trials; Western University","funders":"Janssen Research and Development; Merck Sharp and Dohme; UCB Pharma; Sun Pharma; Tillotts Pharma; Amgen; Seres Therapeutics; Celltrion; Genentech; Janssen Scientific Affairs; Celgene; Biogen; Gilead Sciences; Dr. Falk Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ustekinumab; Medicine; Crohn's disease; Maintenance therapy; Interleukin 23; Monoclonal antibody; Monoclonal; Disease; Immunology; Interleukin; Internal medicine; Antibody; Cytokine; Chemotherapy; Adalimumab","retraction":null,"screen_n_in":null,"score":{"opus":0.01067286993960359,"gpt":0.2590847257424746,"spread":0.248411855802871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003164417,0.00008726201,0.0001129773,0.00004023634,0.00003191377,0.000004890605,0.00007374552,0.00004074569,0.00003804817],"category_scores_gemma":[0.0004755445,0.00004570808,0.00004316179,0.00001735219,0.00008600778,0.000007459609,0.00001117124,0.00004194406,9.516428e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001110449,"about_ca_system_score_gemma":0.0001475783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003202897,"about_ca_topic_score_gemma":0.000004329895,"domain_scores_codex":[0.9994244,0.00003822976,0.0001965384,0.0001064172,0.0001194439,0.0001149844],"domain_scores_gemma":[0.9992996,0.00002534612,0.0001496154,0.0001118717,0.0001534581,0.0002601004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02354994,0.00006581953,0.01706452,0.00004259692,0.0001618386,0.0005197826,0.0002120522,0.00000625164,0.2736859,0.0005649681,0.04329761,0.6408287],"study_design_scores_gemma":[0.1038208,0.002033768,0.4632326,0.0003794294,0.0001028599,0.000567,0.00009039001,0.00000603956,0.005654237,0.005526615,0.4183479,0.0002383631],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906715,0.00132857,0.002487987,0.004915177,0.0003694071,0.0001264878,0.000005124075,0.000002449027,0.00009327169],"genre_scores_gemma":[0.9930682,0.001398155,0.0001266198,0.0005665502,0.00377333,0.00000305215,0.000003208855,0.0000119714,0.001048937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6405903,"threshold_uncertainty_score":0.1863921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122031852","doi":"10.1038/ng2032","title":"Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis","year":2007,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1751,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hôtel-Dieu de Montréal; Mount Sinai Hospital; Université de Montréal; Hospital for Sick Children; Montreal Heart Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Cedars-Sinai Medical Center","keywords":"ATG16L1; Biology; Autophagy; Pathogenesis; Genetics; Disease; Genome-wide association study; Crohn's disease; Gene; Genome; Gene knockdown; Inflammatory bowel disease; Immunology; Single-nucleotide polymorphism; Genotype","retraction":null,"screen_n_in":null,"score":{"opus":0.006254114487951199,"gpt":0.2650976711601485,"spread":0.2588435566721973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006501122,0.000253931,0.0001782398,0.00008604238,0.0001135692,0.00006219422,0.0002233004,0.0003044289,0.000007820657],"category_scores_gemma":[0.0009467778,0.0002711125,0.0001221527,0.0001187135,0.00004532126,0.000007741807,0.000161191,0.0001628196,0.000003254734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001079371,"about_ca_system_score_gemma":0.0002463992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001038203,"about_ca_topic_score_gemma":0.0007545178,"domain_scores_codex":[0.9981728,0.00008269249,0.0003742571,0.0006731817,0.000252691,0.0004444112],"domain_scores_gemma":[0.9985365,0.0000734831,0.0001480007,0.000548953,0.0002056211,0.0004874605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009320506,0.0002549805,0.980337,0.00009034073,0.00006230593,0.0001083416,0.0001253459,0.00005149726,0.01675086,0.000004348964,0.0005227008,0.0007602424],"study_design_scores_gemma":[0.001130818,0.00006495434,0.9937165,0.000004654729,0.0001409875,2.329617e-7,0.0000964082,0.00002345159,0.002031623,0.0006439711,0.001853821,0.0002925668],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928553,0.004920933,0.0003275773,0.0001566037,0.0001620764,0.00135498,0.0001866159,0.00002377055,0.00001220762],"genre_scores_gemma":[0.9977428,0.0001333057,0.0002917275,0.0004480561,0.0004245096,0.00006005673,0.0002958736,0.00004231372,0.0005613636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01471924,"threshold_uncertainty_score":0.9999741,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2611548364","doi":"10.1056/nejmoa1606910","title":"Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1727,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Robarts Clinical Trials; Western University","funders":"Pfizer","keywords":"Tofacitinib; Ulcerative colitis; Medicine; Janus kinase inhibitor; Maintenance therapy; Induction therapy; Janus kinase; Colitis; Internal medicine; Gastroenterology; Chemotherapy; Receptor; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01712734440931054,"gpt":0.2945029057821552,"spread":0.2773755613728447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003825631,0.00007543976,0.0001252067,0.00002324398,0.0001167303,0.00001771975,0.00009952377,0.00004960627,0.00002818079],"category_scores_gemma":[0.000567508,0.00005156014,0.00003317959,0.00000621659,0.0001276472,0.000009106857,0.00001350171,0.00006800685,4.243498e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006378081,"about_ca_system_score_gemma":0.0001040928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001483099,"about_ca_topic_score_gemma":0.00003170668,"domain_scores_codex":[0.9995238,0.00003315365,0.0001647765,0.00008820563,0.0000930631,0.00009702166],"domain_scores_gemma":[0.9992759,0.00001454495,0.0002538327,0.0001347713,0.0001875221,0.0001334531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0268769,0.00007521069,0.02078683,0.00005954843,0.0004071197,0.0004039093,0.001553915,0.00001149316,0.1589797,0.00247993,0.05830684,0.7300586],"study_design_scores_gemma":[0.08574746,0.003312039,0.4686039,0.0001912484,0.00005997121,0.0009593328,0.0003176264,0.00001374954,0.01621014,0.00499675,0.419392,0.0001958226],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946381,0.0003172077,0.000660242,0.003028024,0.0003853086,0.0001296223,0.00000768289,0.000001319542,0.0008324289],"genre_scores_gemma":[0.9941431,0.0008660251,0.0002163808,0.0004492041,0.003583672,0.000002728842,0.000007120523,0.000008102093,0.0007237265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7298628,"threshold_uncertainty_score":0.2102562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152026434","doi":"10.1053/j.gastro.2005.11.030","title":"Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial","year":2006,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1716,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Adalimumab; Monoclonal antibody; Medicine; Crohn's disease; Tumor necrosis factor alpha; Monoclonal; Necrosis; Disease; Tumor necrosis factors; Immunology; Antibody; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.008461342383497378,"gpt":0.2564928122801641,"spread":0.2480314698966667,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001650134,0.0002763911,0.0002365712,0.00007962026,0.0001547343,0.00004595774,0.0004193291,0.0001126392,0.00009300894],"category_scores_gemma":[0.00003313354,0.0002297257,0.0002098999,0.00005424928,0.0002864398,0.000008515609,0.0001915274,0.0001934659,0.00002258312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003485543,"about_ca_system_score_gemma":0.00007993673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009363747,"about_ca_topic_score_gemma":0.0007956644,"domain_scores_codex":[0.9979264,0.0003017744,0.000442119,0.0005238451,0.0001730257,0.0006328325],"domain_scores_gemma":[0.9990928,0.000008972928,0.0001618006,0.0005529828,0.00004939608,0.0001340781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0188114,0.0004334658,0.8157845,0.000019751,0.00005442092,0.0006214171,0.00001528274,0.0001516181,0.1593543,0.0001616917,0.004558329,0.0000338159],"study_design_scores_gemma":[0.01366566,0.0002519222,0.9840403,0.000006904883,0.00002729451,0.00001192701,0.00001015248,0.00005698044,0.0004059979,0.0001179961,0.001261053,0.0001438431],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982251,0.00004660732,0.0001191763,0.0003956816,0.000352894,0.0005462603,0.0001602707,0.00002422663,0.0001298044],"genre_scores_gemma":[0.9976344,0.00000554389,0.00004681032,0.0008892854,0.0006618695,0.0001071973,0.0003371033,0.00003691013,0.0002808679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1682558,"threshold_uncertainty_score":0.9367942,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211050664","doi":"10.1038/s41572-020-0205-x","title":"Ulcerative colitis","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1568,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Ulcerative colitis; Medicine; Inflammatory bowel disease; Disease; Dysplasia; Colorectal cancer; Rectum; Etiology; Intensive care medicine; Internal medicine; Colitis; Gastroenterology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.0184041768749782,"gpt":0.3282481766300998,"spread":0.3098439997551216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003020385,0.0009322918,0.001833586,0.00008698772,0.0001161819,0.0000635216,0.0007322047,0.0009377659,0.0001666003],"category_scores_gemma":[0.000667959,0.0007676745,0.00201687,0.0002734393,0.0001315368,0.000006784021,0.0003031026,0.00100665,0.0007941737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001179836,"about_ca_system_score_gemma":0.001632286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":9.8132e-7,"about_ca_topic_score_gemma":0.000004463917,"domain_scores_codex":[0.9961685,0.0009675776,0.0008444328,0.001233693,0.0003105899,0.0004751917],"domain_scores_gemma":[0.9971091,0.00002332983,0.0006040859,0.001136923,0.0001089141,0.001017689],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001351248,0.00005288622,0.000003764682,0.02395364,0.0003771762,0.0004144277,0.000006948817,1.184793e-7,0.000001128129,0.0002838553,0.04915212,0.9256188],"study_design_scores_gemma":[0.0001904454,0.0000249552,0.00008698746,0.005110895,0.001985318,0.00001091882,0.000001776267,6.10546e-7,0.000001317616,0.00001225354,0.9917932,0.0007813759],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001457335,0.9941568,0.00001726922,0.00004259811,0.0004420332,0.003209735,0.0005324978,0.00004391606,0.001553691],"genre_scores_gemma":[0.000003496796,0.9931309,0.0002490875,0.001101195,0.001189551,0.0007312648,0.002821305,0.0001551496,0.0006180088],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.942641,"threshold_uncertainty_score":0.9999838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132784721","doi":"10.1136/gutjnl-2011-301668","title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","year":2012,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1495,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Novartis Institutes for BioMedical Research; National Institutes of Health","keywords":"Secukinumab; Placebo; Medicine; Internal medicine; Clinical endpoint; Adverse effect; Crohn's disease; Confidence interval; Randomized controlled trial; Gastroenterology; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02124235727899869,"gpt":0.3076641879383812,"spread":0.2864218306593825,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005992023,0.0003535334,0.0005688353,0.0001177852,0.0001892956,0.00004886006,0.0002930677,0.0002078856,0.00003190288],"category_scores_gemma":[0.0003236671,0.0003263781,0.0004856748,0.00009894828,0.00007641155,0.00001850011,0.0001318411,0.00009317291,0.00001544793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002910217,"about_ca_system_score_gemma":0.0002808886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000144,"about_ca_topic_score_gemma":0.0000187509,"domain_scores_codex":[0.9976911,0.0001682388,0.0007350926,0.0005196571,0.0002748779,0.0006110299],"domain_scores_gemma":[0.9982176,0.00005426171,0.0003167165,0.000635937,0.0002769709,0.0004984967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8726375,0.0003680511,0.000159822,0.00006085238,0.0003009612,0.00002922918,0.0001304211,0.0005152604,0.1234614,0.0001333653,0.002167099,0.00003609786],"study_design_scores_gemma":[0.9809395,0.0002497071,0.004322432,0.00003162647,0.0002600105,0.000003503861,0.00002815824,0.0003092735,0.01127613,0.00005391102,0.002057577,0.000468176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990231,0.0001640503,0.000753791,0.00008390407,0.0003645543,0.00694346,0.000664585,0.00003346412,0.0007611692],"genre_scores_gemma":[0.9946601,0.000008197896,0.0003718591,0.0001047358,0.001086249,0.001218618,0.001153816,0.00005782381,0.001338645],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1121852,"threshold_uncertainty_score":0.9999188,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2153915282","doi":"10.1002/ibd.21493","title":"Pediatric modification of the Montreal classification for inflammatory bowel disease","year":2010,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1474,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hospital for Sick Children","funders":"Crohn's and Colitis Foundation; Crohn's and Colitis Foundation of America","keywords":"Ulcerative colitis; Inflammatory bowel disease; Medicine; Disease; Phenotype; Ileum; Crohn's disease; Clinical phenotype; De facto; Internal medicine; Gene; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.009806635338076686,"gpt":0.2399044163133596,"spread":0.2300977809752829,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003011587,0.0004204672,0.0002030762,0.0001370366,0.0003436495,0.00006207173,0.0008731081,0.0002694885,0.00003938723],"category_scores_gemma":[0.0008672496,0.0003665727,0.0005383151,0.000124204,0.0003932591,0.00004541251,0.000198785,0.0002110015,0.00002682079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003584186,"about_ca_system_score_gemma":0.0008762869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005710384,"about_ca_topic_score_gemma":0.00009493141,"domain_scores_codex":[0.997415,0.000157657,0.0007577256,0.0007103416,0.0004782682,0.0004810196],"domain_scores_gemma":[0.9965962,0.00006552363,0.0006010645,0.001737106,0.0004896015,0.0005105586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00124249,0.0003295269,0.9140311,0.0006163892,0.0000798211,0.00001617948,0.00006758049,0.0005576763,0.07379749,0.003191633,0.005460578,0.0006095527],"study_design_scores_gemma":[0.001127373,0.00002809839,0.9907248,0.00001932829,0.000273805,0.000001894473,0.00004763545,0.001454609,0.002312249,0.0008821007,0.002693941,0.0004341855],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957127,0.0003210815,0.0002397368,0.0001414035,0.0008516787,0.001576862,0.0007651717,0.00008762268,0.0003037231],"genre_scores_gemma":[0.9968324,0.00007576941,0.0001066391,0.0001506606,0.001227059,0.0007750903,0.0003942419,0.00009186421,0.0003462443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07669371,"threshold_uncertainty_score":0.9998786,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156250460","doi":"10.1136/gut.2010.224154","title":"Guidelines for the management of inflammatory bowel disease in adults","year":2011,"lang":"en","type":"review","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1439,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Audit; Disease; Disease management; Health care; Family medicine; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04192433364978712,"gpt":0.3264395341756606,"spread":0.2845152005258734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000281835,0.0002905587,0.0003455328,0.00005898012,0.00003429618,0.000007295205,0.0005306717,0.0001635603,0.00001603747],"category_scores_gemma":[0.00007455731,0.0002024642,0.0004671284,0.00004632285,0.00007292956,0.000002141827,0.0002250934,0.00007187406,0.00002036259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001709903,"about_ca_system_score_gemma":0.0001967792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004679536,"about_ca_topic_score_gemma":0.00001773053,"domain_scores_codex":[0.9985877,0.00005724825,0.0006580614,0.000364605,0.0001037214,0.000228625],"domain_scores_gemma":[0.9986225,0.00001436385,0.0002897457,0.0008304652,0.0001531081,0.00008981978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007019641,0.0001307463,0.0003680802,0.1198967,0.0008705007,0.0001578065,0.00003463955,0.00003173935,0.000002343508,0.002049553,0.01198931,0.8637666],"study_design_scores_gemma":[0.0003757016,0.00001548302,0.001756239,0.005948341,0.0004927645,8.331023e-7,0.00001284148,0.00001413955,0.000001445542,0.00004551611,0.9910964,0.0002402409],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002234238,0.9971721,0.00006968719,0.00001220076,0.000218077,0.001758429,0.0001925133,0.000007759658,0.000345823],"genre_scores_gemma":[0.00005903751,0.9972919,0.0003148315,0.00005772274,0.0002496222,0.0009054379,0.0002757054,0.00005278317,0.0007929132],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9791071,"threshold_uncertainty_score":0.8256251,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385728359","doi":"10.1016/s0140-6736(23)00966-2","title":"Ulcerative colitis","year":2023,"lang":"en","type":"review","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1425,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Ulcerative colitis; Medicine; Gastroenterology; Inflammatory bowel disease; Genetic predisposition; Internal medicine; Tofacitinib; Colitis; Disease; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.05496308272484146,"gpt":0.3395983517452794,"spread":0.284635269020438,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002443938,0.0001979113,0.0005659068,0.00001752492,0.00007178904,0.00003121603,0.0004890662,0.0001632583,0.00003198648],"category_scores_gemma":[0.00007052985,0.0001252614,0.0002288974,0.00006824767,0.0000718263,6.421323e-7,0.0001720962,0.000149761,0.0007402654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001529401,"about_ca_system_score_gemma":0.0001805199,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000471293,"about_ca_topic_score_gemma":0.00005587238,"domain_scores_codex":[0.9990149,0.0002347573,0.0001814002,0.0002442787,0.00008411905,0.0002405061],"domain_scores_gemma":[0.9990258,0.00002311418,0.0001096871,0.0007690936,0.0000275535,0.00004480231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001510343,0.00002197068,0.000009072161,0.01412802,0.0008962577,0.0002890483,0.00006926461,0.000002469159,0.00000376799,0.002990254,0.5655339,0.415905],"study_design_scores_gemma":[0.0001185942,0.00001111546,0.0001778746,0.0007989756,0.0001413358,0.00001010562,0.000004633253,5.107125e-7,0.000001649525,0.00007716459,0.9984978,0.0001602071],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004285224,0.9938143,0.000005142632,0.0000464289,0.0002298536,0.0004890594,0.0003529241,0.00004002927,0.004979446],"genre_scores_gemma":[0.000005065602,0.9912315,0.00001438929,0.000201161,0.002856031,0.0001876342,0.0004535189,0.00005363891,0.004997056],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.432964,"threshold_uncertainty_score":0.9514861,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160011929","doi":"10.1097/mpg.0000000000000239","title":"ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents","year":2013,"lang":"en","type":"article","venue":"Journal of Pediatric Gastroenterology and Nutrition","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1377,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Crohn's and Colitis UK","keywords":"Medicine; Ulcerative colitis; Inflammatory bowel disease; Capsule endoscopy; Colonoscopy; Disease; Gastroenterology; Pathology; Internal medicine; Colorectal cancer; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.00472015059212966,"gpt":0.2257556360965745,"spread":0.2210354855044448,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000244421,0.00009829186,0.0001317937,0.0001019988,0.00003807309,0.00001218202,0.00009268123,0.00006837136,0.000006534168],"category_scores_gemma":[0.00009568632,0.00007804778,0.0000796278,0.00002285636,0.00007661386,0.00001892174,0.00004059912,0.00008146298,2.413335e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006029084,"about_ca_system_score_gemma":0.00002282963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002382941,"about_ca_topic_score_gemma":0.000003850252,"domain_scores_codex":[0.9991959,0.00009880664,0.0003671375,0.0001201203,0.00006968305,0.0001483878],"domain_scores_gemma":[0.9993539,0.00001712197,0.000294937,0.00009807472,0.0001233591,0.0001125489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001768134,0.0001648849,0.9948475,0.0001750142,0.00002965816,0.00000696121,0.00001191436,0.000003111859,0.0008968253,0.000001831954,0.00199256,0.0001016145],"study_design_scores_gemma":[0.002763363,0.0004135164,0.9963627,0.00004290233,0.000124321,0.00002285557,0.00001490079,0.00002659442,0.00007738818,0.00008336169,0.00002266824,0.00004539152],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972546,0.00176221,0.00009774236,0.0003063479,0.00007621926,0.0004688453,0.00003254015,0.000001245524,2.999608e-7],"genre_scores_gemma":[0.9947264,0.004417095,0.0001094626,0.0001560396,0.0004986522,0.00006612373,0.00001614746,0.000008379659,0.000001655304],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002654885,"threshold_uncertainty_score":0.3182696,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980725116","doi":"10.1038/ng.764","title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","year":2011,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1353,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Mount Sinai Hospital; SickKids Foundation; University of Toronto; Hôpital Maisonneuve-Rosemont; Université de Montréal; Montreal Heart Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Else Kröner-Fresenius-Stiftung; Shire; National Heart, Lung, and Blood Institute; Exzellenzclusters Entzündungsforschung; National Institutes of Health; Svenska Läkaresällskapet; Adessium Foundation; Karolinska Institutet; Fonds Wetenschappelijk Onderzoek; Crohn's and Colitis UK; Fonds De La Recherche Scientifique - FNRS; Cedars-Sinai Medical Center; Deutsche Forschungsgemeinschaft; National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Center for Advancing Translational Sciences; Leona M. and Harry B. Helmsley Charitable Trust; Medical Research Council; Swedish Cancer Foundation; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; ALS Association; Wellcome Trust; National Institute for Health and Care Research; Abbott Laboratories; National Health and Medical Research Council","keywords":"Biology; Ulcerative colitis; Genetics; Meta-analysis; Computational biology; Internal medicine; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.0359468060502631,"gpt":0.3296221768317765,"spread":0.2936753707815134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006595878,0.0004549006,0.001436205,0.0001316526,0.0002152402,0.00006076264,0.0005757263,0.001027393,0.002551591],"category_scores_gemma":[0.0008300413,0.0003328845,0.002587311,0.0004681798,0.0001612723,0.000003415616,0.0002331893,0.0006203104,0.00006735099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005597279,"about_ca_system_score_gemma":0.0005116251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003298553,"about_ca_topic_score_gemma":0.0005953933,"domain_scores_codex":[0.9968383,0.001167723,0.0007396914,0.0005575214,0.0004030867,0.0002937172],"domain_scores_gemma":[0.9969947,0.0002434951,0.0009687276,0.000866955,0.000781236,0.0001449283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002246673,0.0003496567,0.001252101,0.002165179,0.8370994,0.00005776085,0.0005260101,0.0001205092,0.00001496891,0.001162118,0.1328875,0.02414017],"study_design_scores_gemma":[0.00008680694,0.00001507909,0.01020326,0.00004705284,0.2365508,0.000008759468,0.0000221281,0.000001680185,0.00004780276,0.0001361621,0.7525051,0.000375363],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001121064,0.9465073,0.00009040339,0.00001606854,0.0001812139,0.0009488877,0.04950479,0.0000117261,0.001618563],"genre_scores_gemma":[0.004030067,0.9742533,0.001554966,0.0003159034,0.0005636578,0.0004629744,0.017146,0.00008406193,0.001589064],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6196176,"threshold_uncertainty_score":0.9999123,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211167126","doi":"10.1093/ecco-jcc/jjz180","title":"ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment","year":2019,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1344,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Aalborg Universitet; National Institute for Health and Care Research; European Crohn's and Colitis Organisation","keywords":"Medicine; Crohn's disease; Intensive care medicine; Inflammatory bowel disease; Disease; Infliximab; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01550007926252451,"gpt":0.2945571734980789,"spread":0.2790570942355544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000167135,0.0001096319,0.0001479459,0.00004673066,0.00002258866,0.00002380905,0.00009869513,0.0000827131,0.0001114687],"category_scores_gemma":[0.00005274587,0.00008175287,0.0000964879,0.00002562052,0.00004053722,0.000004879363,0.00002540414,0.00006671902,0.000007216397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002667639,"about_ca_system_score_gemma":0.0002904152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000569814,"about_ca_topic_score_gemma":0.00002760585,"domain_scores_codex":[0.9991379,0.00004872943,0.0003163666,0.0001216215,0.0002261314,0.0001491913],"domain_scores_gemma":[0.999394,0.00001149101,0.000111758,0.0001466953,0.0001265602,0.0002095139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07248441,0.002627176,0.5320212,0.0003617632,0.00118224,0.03776694,0.0005184904,0.0006842643,0.00330097,0.006388083,0.01648407,0.3261804],"study_design_scores_gemma":[0.001348069,0.0002823732,0.9300821,0.00007474681,0.00002412762,0.00004534249,0.00003542837,0.00006913669,0.000295629,0.0001749229,0.06747267,0.00009546683],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969743,0.001296937,0.00001029871,0.0008503445,0.0001740679,0.0001071685,0.00001555609,0.000001687599,0.0005695916],"genre_scores_gemma":[0.9954308,0.00189978,0.00005514537,0.001477766,0.0003575173,0.000003981531,0.000005409999,0.00001196701,0.0007576349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3980609,"threshold_uncertainty_score":0.3333785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3092547488","doi":"10.1038/s41575-020-00360-x","title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Gastroenterology & Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1258,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Epidemiology; Medicine; Disease; Incidence (geometry); Inflammatory bowel disease; Pandemic; Population; Global health; Environmental health; Demography; Public health; Coronavirus disease 2019 (COVID-19); Pathology; Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.01916409756989251,"gpt":0.3130757786732901,"spread":0.2939116811033975,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002480548,0.0008810918,0.002397816,0.00008552163,0.0001643981,0.00001866377,0.002048553,0.001597543,0.00001140214],"category_scores_gemma":[0.003039601,0.0004771,0.001590839,0.0002360694,0.0008860294,0.000008042924,0.0005621026,0.001832747,0.00004601619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002228424,"about_ca_system_score_gemma":0.0006523521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000380855,"about_ca_topic_score_gemma":0.0003299393,"domain_scores_codex":[0.9868011,0.008859872,0.002071871,0.001076687,0.0002602786,0.0009301393],"domain_scores_gemma":[0.9962993,0.0002908309,0.001535415,0.001500464,0.0001148357,0.0002591311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002727971,0.0003792018,0.731178,0.02004712,0.001023264,0.002778284,0.00002715916,0.000008940883,0.000005742435,0.009225485,0.0323534,0.2002455],"study_design_scores_gemma":[0.0003645876,0.0002297514,0.02481047,0.0008019677,0.0006251322,0.000299804,0.000008412642,0.000008476532,8.123866e-8,0.0002893059,0.9723265,0.0002355202],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00297333,0.9927024,0.0001001449,0.0009578482,0.0005584431,0.002394586,0.0002397444,0.00001823427,0.00005529165],"genre_scores_gemma":[0.005527629,0.991179,0.00006949015,0.001641182,0.0004453092,0.0007878704,0.0002966778,0.00004175206,0.00001110814],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9399731,"threshold_uncertainty_score":0.9997681,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152381563","doi":"10.1016/s0140-6736(08)60304-9","title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1238,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Immunosuppression; Azathioprine; Infliximab; Crohn's disease; Internal medicine; Randomized controlled trial; Inflammatory bowel disease; Surgery; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01611488503414071,"gpt":0.2597062046537114,"spread":0.2435913196195706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001906111,0.0001333643,0.0001915613,0.00002103867,0.000131826,0.00004840583,0.0006095791,0.00003975062,0.00009937765],"category_scores_gemma":[0.00003861399,0.00008122119,0.00004039321,0.0000503855,0.00008940115,0.00001589167,0.0002099258,0.00006354519,0.00001048621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001308903,"about_ca_system_score_gemma":0.00007644976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001380115,"about_ca_topic_score_gemma":0.00001450493,"domain_scores_codex":[0.9989395,0.0002184626,0.0001886781,0.0002482074,0.0001926146,0.0002126068],"domain_scores_gemma":[0.9991677,0.000014711,0.00008795984,0.0005982382,0.00004181571,0.00008952327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9277795,0.0006474536,0.06537336,0.00001803829,0.00009368848,0.0004264346,0.00005039172,0.00006540395,0.0001141078,0.00008611577,0.00513677,0.0002087176],"study_design_scores_gemma":[0.3072969,0.0002724665,0.6913449,0.00002021465,0.00002103383,2.611607e-7,0.000006432214,0.00001262166,0.00002868214,0.00003185585,0.0008582687,0.0001063321],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970799,0.000022838,0.00002060305,0.00008693606,0.0001077854,0.002180372,0.00005774056,0.00001143339,0.0004323916],"genre_scores_gemma":[0.9977514,0.00003467265,0.0001521177,0.0003059575,0.0001875602,0.0003548506,0.0004917357,0.00001979277,0.0007018856],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6259716,"threshold_uncertainty_score":0.3312104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2536753757","doi":"10.1053/j.gastro.2016.10.020","title":"Understanding and Preventing the Global Increase of Inflammatory Bowel Disease","year":2016,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1212,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Inflammatory bowel disease; Medicine; Intensive care medicine; Inflammatory Bowel Diseases; Disease; Gastroenterology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02682537562667441,"gpt":0.2755597320497462,"spread":0.2487343564230717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003608431,0.0003738141,0.0005119742,0.0000531228,0.00009411701,0.00001716084,0.0003915658,0.0002100906,0.00001957138],"category_scores_gemma":[0.0001504029,0.0002466632,0.0003660284,0.00003310209,0.0004498099,0.000005197648,0.0005335345,0.0001293941,0.000008099389],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008234115,"about_ca_system_score_gemma":0.0002322254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001544786,"about_ca_topic_score_gemma":0.0000296302,"domain_scores_codex":[0.9978418,0.0005732542,0.0005461771,0.0004774846,0.0001333555,0.0004278652],"domain_scores_gemma":[0.9985828,0.00003068958,0.000496042,0.0006187487,0.00003910879,0.0002325977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006006699,0.0004963186,0.7830034,0.06442552,0.005352171,0.001445586,0.00007855769,0.00001535495,0.00009460963,0.008731528,0.008116258,0.122234],"study_design_scores_gemma":[0.00375561,0.0006372445,0.06948627,0.01280837,0.003666192,0.0005625917,0.00008387404,0.00001753851,0.00000319754,0.001995614,0.9057893,0.001194205],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02624199,0.9712305,0.0007776493,0.0000524129,0.00024735,0.0007842292,0.0004767753,0.00001797378,0.000171092],"genre_scores_gemma":[0.01554867,0.9836701,0.00003107325,0.0001189865,0.000299613,0.00009733949,0.0001237946,0.00004607312,0.00006435114],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.897673,"threshold_uncertainty_score":0.9999986,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056629400","doi":"10.1053/j.gastro.2006.12.038","title":"A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis","year":2006,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1208,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University of Calgary; St. Michael's Hospital; Western University","funders":"","keywords":"Ulcerative colitis; Medicine; Medical therapy; Internal medicine; Clinical trial; Gastroenterology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.06095522535698546,"gpt":0.4186429310790992,"spread":0.3576877057221138,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00446002,0.0003187147,0.00274931,0.00009411084,0.00001396556,0.000003474017,0.0002817403,0.0005088003,0.00003184123],"category_scores_gemma":[0.001404855,0.0002281011,0.0005332721,0.00005039855,0.0004484901,0.000003335791,0.0001037175,0.0002381893,3.280781e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001169147,"about_ca_system_score_gemma":0.000395909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001631428,"about_ca_topic_score_gemma":0.0004328683,"domain_scores_codex":[0.9940187,0.00332086,0.001670553,0.0005187856,0.0001937287,0.0002773109],"domain_scores_gemma":[0.9973807,0.0004151286,0.001638187,0.0003325219,0.0001113606,0.0001220531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01879794,0.0009961819,0.007583204,0.1044323,0.001088678,0.00006675605,0.00002508588,9.550441e-8,0.000003068114,0.00001807872,0.002050517,0.8649381],"study_design_scores_gemma":[0.04232167,0.01865571,0.1361363,0.246045,0.002071396,0.0002995739,0.00001856621,0.000006639773,0.00003976615,0.00002149898,0.5535784,0.0008053705],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1160717,0.8805379,0.00007273816,0.00007398513,0.00007501965,0.002526822,0.0006276686,0.000002949405,0.00001123726],"genre_scores_gemma":[0.002287312,0.9963388,0.0001278599,0.0002809408,0.0001601338,0.0003090333,0.0004638588,0.00002868135,0.000003305801],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8641327,"threshold_uncertainty_score":0.9301695,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205253993","doi":"10.1056/nejmoa1900750","title":"Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1180,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Janssen Research and Development","keywords":"Ustekinumab; Medicine; Maintenance therapy; Randomization; Placebo; Ulcerative colitis; Internal medicine; Gastroenterology; Surgery; Randomized controlled trial; Chemotherapy; Disease; Adalimumab","retraction":null,"screen_n_in":null,"score":{"opus":0.008702714478102707,"gpt":0.2584245139701914,"spread":0.2497217994920888,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003373641,0.00007754658,0.0001340314,0.00003454752,0.00002419951,0.00000598753,0.00005641039,0.00005215178,0.0000582297],"category_scores_gemma":[0.0001522663,0.00005239214,0.00003294943,0.00002047023,0.00004796234,0.0000061393,0.000008498124,0.00007291873,0.000001535311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001050133,"about_ca_system_score_gemma":0.0001192299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008397616,"about_ca_topic_score_gemma":0.00001417487,"domain_scores_codex":[0.9994784,0.00004567614,0.0001781584,0.00009380497,0.0001052025,0.0000987668],"domain_scores_gemma":[0.9994581,0.00002122031,0.0001486207,0.00008301139,0.0001770604,0.0001119422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04936836,0.0001216478,0.02834246,0.0001405837,0.0006102018,0.0002642004,0.002696542,0.0001077039,0.4171624,0.002867254,0.0688767,0.429442],"study_design_scores_gemma":[0.1539259,0.009096745,0.2879097,0.0003190883,0.00008684256,0.001786642,0.0009339635,0.00005275435,0.01660886,0.003908841,0.5250481,0.0003226485],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965916,0.0004900624,0.0004515831,0.001222391,0.0004370187,0.0001916588,0.000002945768,0.000001539317,0.0006112354],"genre_scores_gemma":[0.9948936,0.0005884473,0.0001756728,0.0006025711,0.002413233,0.000002089719,0.00000771709,0.000009632392,0.001307004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4561714,"threshold_uncertainty_score":0.2136489,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093690138","doi":"10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z","title":"Cancer risk in patients with inflammatory bowel disease","year":2001,"lang":"en","type":"article","venue":"Cancer","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"CancerCare Manitoba; Manitoba Health; University of Manitoba","funders":"","keywords":"Medicine; Internal medicine; Inflammatory bowel disease; Ulcerative colitis; Incidence (geometry); Population; Gastroenterology; Cancer; Cancer registry; Rate ratio; Colorectal cancer; Crohn's disease; Disease; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.003459591873264266,"gpt":0.2193121345728289,"spread":0.2158525426995646,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005182485,0.0001622803,0.00008302765,0.00004047375,0.00005318099,0.00001369559,0.00013777,0.00006803337,0.0002069174],"category_scores_gemma":[0.00002699674,0.0001433032,0.00004501197,0.00006607499,0.00007291987,0.000008240364,0.00005015188,0.0000897271,0.00001606814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007386439,"about_ca_system_score_gemma":0.0002772286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005577644,"about_ca_topic_score_gemma":0.0007861608,"domain_scores_codex":[0.9990551,0.00004423095,0.0001459077,0.0003240311,0.0001511996,0.0002795405],"domain_scores_gemma":[0.9992818,0.000002616789,0.00008248595,0.0003398375,0.00009261433,0.0002006911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001385936,0.0000598021,0.9939165,0.0000235702,0.00003360122,0.0000539966,0.00002414806,0.002004728,0.0001520248,0.000007144855,0.001245699,0.00109285],"study_design_scores_gemma":[0.001673761,0.00002499009,0.9849518,0.00004101576,0.00002931976,1.09994e-7,0.000007065537,0.00005361608,0.0001436997,0.00001416522,0.01283212,0.0002283637],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981849,0.0008711892,0.00001819481,0.00004311618,0.000156652,0.0002800692,0.0001326646,0.00001480107,0.0002984607],"genre_scores_gemma":[0.9978262,0.0006303496,0.00001318425,0.0003628066,0.0002346983,0.0002629047,0.00006107983,0.00003467859,0.0005740856],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01158642,"threshold_uncertainty_score":0.5843734,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166360124","doi":"10.1056/nejmoa067594","title":"Certolizumab Pegol for the Treatment of Crohn's Disease","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1140,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"National Center for Research Resources; Towson University; University of South Carolina; University of Louisville","keywords":"Certolizumab pegol; Medicine; Placebo; Crohn's disease; Internal medicine; Randomized controlled trial; Gastroenterology; Disease; Adalimumab; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01326523126089393,"gpt":0.2802427581146855,"spread":0.2669775268537916,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001938615,0.00009504463,0.0001490405,0.00004120997,0.00003838026,0.000002678807,0.00011897,0.00003330789,0.00003458783],"category_scores_gemma":[0.0002107179,0.00004917674,0.0001196546,0.00002837105,0.0000862937,0.000002206139,0.000006843532,0.0000343106,4.321933e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001744157,"about_ca_system_score_gemma":0.0001600051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009728787,"about_ca_topic_score_gemma":0.00003285844,"domain_scores_codex":[0.9992933,0.00002476782,0.0003093424,0.00007476705,0.0001643697,0.0001334479],"domain_scores_gemma":[0.9991311,0.00008718423,0.0002084929,0.0001773166,0.0001592495,0.000236699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.08414173,0.0008919555,0.03441496,0.0001908509,0.001186496,0.008245042,0.002193746,0.0002989096,0.06546586,0.000697852,0.03351909,0.7687535],"study_design_scores_gemma":[0.07441541,0.004218046,0.377337,0.0001056613,0.0007405481,0.0006203038,0.0002966537,0.00005813193,0.009017745,0.000508857,0.532505,0.0001766473],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848627,0.004922436,0.006571552,0.002650222,0.0005141576,0.0002465536,0.0000108268,0.000001937902,0.0002196086],"genre_scores_gemma":[0.9942151,0.0007241916,0.000152581,0.000087447,0.004347124,0.000001955573,0.000008925836,0.00001070972,0.0004519751],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7685769,"threshold_uncertainty_score":0.2005369,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2133936908","doi":"10.1097/00054725-200002000-00002","title":"A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998","year":2000,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1140,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; McMaster University","funders":"","keywords":"Crohn's disease; Disease; Medicine; Categorization; Internal medicine; Ileitis; Crohn disease; Gastroenterology; Artificial intelligence; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.01299992860128393,"gpt":0.2553555843778277,"spread":0.2423556557765438,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002733904,0.0002382744,0.0002575352,0.00005603456,0.0001522467,0.00001543429,0.0005860823,0.00007450036,0.0001009442],"category_scores_gemma":[0.0002865121,0.0001653916,0.0004562694,0.0001159652,0.0007057677,0.00001471519,0.0001239848,0.00007368157,0.000002212112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001561084,"about_ca_system_score_gemma":0.0002929388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005475965,"about_ca_topic_score_gemma":0.0001857715,"domain_scores_codex":[0.9980361,0.0001779933,0.0008100017,0.0003724135,0.0002953002,0.0003081564],"domain_scores_gemma":[0.9976534,0.0001162067,0.000713465,0.001160615,0.000206059,0.0001502019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004309462,0.0002290314,0.9775513,0.0003892819,0.0002202677,0.00003670021,0.00003442041,0.0007795698,0.01144201,0.0002610117,0.004235381,0.000511498],"study_design_scores_gemma":[0.0007423555,0.00004986685,0.9764365,0.0001134207,0.0002798701,0.000004956432,0.0000531012,0.0003017039,0.00337888,0.0002006446,0.01829816,0.0001405712],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997131,0.0007739362,0.00006666378,0.000125487,0.0001615084,0.0009011282,0.0006471626,0.00001673834,0.0001763008],"genre_scores_gemma":[0.9987614,0.00007595964,0.00002689375,0.000119738,0.0001654498,0.0002566414,0.0001904813,0.00003455093,0.0003688809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01406278,"threshold_uncertainty_score":0.6744475,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085127303","doi":"10.1056/nejmoa1203572","title":"Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1128,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Robarts Clinical Trials; University of Calgary","funders":"","keywords":"Medicine; Ustekinumab; Crohn's disease; Refractory (planetary science); Maintenance therapy; Induction therapy; Crohn disease; Rescue therapy; Disease; Intensive care medicine; Internal medicine; Infliximab; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.0124944485353163,"gpt":0.2569001464588903,"spread":0.244405697923574,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005217595,0.00008990164,0.0001218956,0.00007110063,0.00001952479,0.000003954142,0.00006497589,0.00004887134,0.00003498895],"category_scores_gemma":[0.0002511427,0.00006148314,0.00002677328,0.00003735849,0.00007065546,0.0000149352,0.00001456282,0.0001365397,8.180758e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001715021,"about_ca_system_score_gemma":0.000092493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001005791,"about_ca_topic_score_gemma":0.000009538024,"domain_scores_codex":[0.9993159,0.00008556039,0.0002258871,0.00007790292,0.0001408683,0.0001538974],"domain_scores_gemma":[0.9993479,0.00001280026,0.0001457448,0.0001111904,0.00006569963,0.0003166707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01314252,0.0002846871,0.5341669,0.00006172642,0.0001113528,0.001333005,0.001472144,0.00004286734,0.1014568,0.0001924666,0.01758161,0.330154],"study_design_scores_gemma":[0.01629229,0.0002621879,0.9217723,0.00008110581,0.00001755618,0.0001579352,0.00009026986,0.000003024625,0.0002789922,0.0001260821,0.06083921,0.00007901501],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934865,0.005021521,0.00009673931,0.0007208392,0.0004318326,0.00006440799,0.000001112533,0.000001692977,0.0001753867],"genre_scores_gemma":[0.9937385,0.001767114,0.0000607024,0.0003675239,0.003867385,0.000001009386,0.000004333081,0.00000996663,0.0001834407],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3876055,"threshold_uncertainty_score":0.250721,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2984128211","doi":"10.1093/ecco-jcc/jjz187","title":"ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment","year":2019,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1117,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Institute for Health and Care Research; European Crohn's and Colitis Organisation","keywords":"Medicine; Crohn's disease; Intensive care medicine; Disease; General surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01759076183135743,"gpt":0.2917010131604724,"spread":0.2741102513291149,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001205138,0.0001148852,0.0001535185,0.00004697001,0.00002373744,0.00002958479,0.00007561051,0.00006282729,0.00005491245],"category_scores_gemma":[0.00001576913,0.00008649033,0.0001124319,0.00002598095,0.00003231154,0.000005304846,0.00002102412,0.00005471297,0.000007012465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003010348,"about_ca_system_score_gemma":0.0001547914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005172372,"about_ca_topic_score_gemma":0.0000151787,"domain_scores_codex":[0.9992347,0.00004883768,0.000305535,0.0001260262,0.0001327609,0.0001520826],"domain_scores_gemma":[0.9994553,0.00001100545,0.0001144064,0.0001479329,0.0001283087,0.0001430506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1089137,0.002427972,0.6567863,0.0002905538,0.001009037,0.04209614,0.0004527507,0.001632115,0.003534054,0.00863166,0.008469788,0.1657559],"study_design_scores_gemma":[0.001503194,0.0002809462,0.8758883,0.0000441528,0.00002455136,0.00005932001,0.00003193892,0.00003629686,0.0003057482,0.0001403567,0.1215865,0.00009873215],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967743,0.001897918,0.000003203694,0.0003796084,0.0001451782,0.0001184464,0.00002202962,0.000001701487,0.0006576283],"genre_scores_gemma":[0.9960924,0.001648261,0.00005010648,0.0003840283,0.000319983,0.000004110548,0.000005926544,0.00001199798,0.001483156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.219102,"threshold_uncertainty_score":0.3526973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135936774","doi":"10.1016/j.crohns.2014.04.005","title":"Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease","year":2014,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1070,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pediatric gastroenterology; Crohn's disease; Disease; Hepatology; Intensive care medicine; Pediatrics; Inflammatory bowel disease; Disease management; Parenteral nutrition; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01244206130810759,"gpt":0.267148557072265,"spread":0.2547064957641574,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005462962,0.00009380855,0.0001554421,0.00004266788,0.00003962874,0.00001024885,0.0001775524,0.00005603542,0.00005818683],"category_scores_gemma":[0.0003086358,0.00006298866,0.0001263431,0.00003956406,0.0001316741,0.000002047159,0.00007155888,0.00006650301,9.798455e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004569798,"about_ca_system_score_gemma":0.000121624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003185375,"about_ca_topic_score_gemma":0.000003380308,"domain_scores_codex":[0.9988545,0.00009865374,0.0004823135,0.0000981714,0.0003448624,0.0001215361],"domain_scores_gemma":[0.9989048,0.00003787668,0.0003411862,0.0001964542,0.0003192419,0.00020048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0992603,0.003524965,0.1431091,0.006774412,0.004195903,0.0271775,0.0004360082,0.001149423,0.00297535,0.1457706,0.4358442,0.1297822],"study_design_scores_gemma":[0.0008494146,0.0001808075,0.9882872,0.00009736066,0.0001498451,0.00003111708,0.00007634613,0.00006931677,0.0005735587,0.0006264944,0.008967495,0.00009109503],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972389,0.0006181653,0.00008728534,0.0009875763,0.0001264046,0.00009128837,0.00002433797,0.00000120149,0.0008248739],"genre_scores_gemma":[0.997887,0.0009221124,0.000116578,0.0004324592,0.0004595547,0.000002705544,0.00000213351,0.000008745313,0.000168761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8451781,"threshold_uncertainty_score":0.2568603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107045048","doi":"10.1053/j.gastro.2007.05.029","title":"Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study","year":2007,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1067,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; St. Michael's Hospital; Children's Hospital of Eastern Ontario; University of Ottawa; University of Toronto; Dalhousie University; SickKids Foundation; Institute for Work & Health; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"University of Toronto; Crohn's and Colitis Foundation of Canada; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation","keywords":"Medicine; Ulcerative colitis; Intraclass correlation; Prospective cohort study; Cohort; Internal medicine; Receiver operating characteristic; Colonoscopy; Disease; Psychometrics; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01388309154401655,"gpt":0.2856447570469421,"spread":0.2717616655029256,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001022715,0.0001225988,0.0001214343,0.00008592116,0.00005777702,0.000007313913,0.00006760351,0.00006532521,0.0000152671],"category_scores_gemma":[0.00009542631,0.0001278335,0.00002600502,0.00004492103,0.00006265489,0.000008274161,0.00009530305,0.00006191337,0.000001889507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004372127,"about_ca_system_score_gemma":0.00009049032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006442745,"about_ca_topic_score_gemma":0.00109403,"domain_scores_codex":[0.9987734,0.0002733569,0.0002304262,0.0003027261,0.0001974321,0.0002226656],"domain_scores_gemma":[0.9992446,0.000008635689,0.0001620078,0.0001555478,0.0003603143,0.00006890364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003001747,0.0003723411,0.9919183,0.00001086425,0.000104526,0.000005731872,0.0006990363,0.00001840242,0.003075414,0.000001990843,0.00001816575,0.0007735273],"study_design_scores_gemma":[0.003627999,0.0003847483,0.9907627,0.000001623986,0.00008290019,0.000003764056,0.0002996444,0.00006108385,0.004691726,0.0000102242,0.000009254962,0.00006438633],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970518,0.000006258732,0.001873869,0.000007079339,0.0000728604,0.0009048817,0.000009590935,0.000006452496,0.00006718186],"genre_scores_gemma":[0.999342,0.000002316168,0.0003973884,0.00003497335,0.00009325991,0.00008758259,0.00002058841,0.00001067948,0.00001121618],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00229017,"threshold_uncertainty_score":0.5212896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2991550463","doi":"10.1155/2019/7247238","title":"A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease","year":2019,"lang":"en","type":"review","venue":"Journal of Immunology Research","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1059,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba; Research Manitoba","funders":"","keywords":"Pathogenesis; Inflammatory bowel disease; Disease; Medicine; Immunology; Inflammation; Immune system; Inflammatory Bowel Diseases; Ulcerative colitis; Bioinformatics; Biology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.06249176863190604,"gpt":0.369546587839345,"spread":0.3070548192074389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001905658,0.000328137,0.001151159,0.0003019061,0.0001112473,0.00002018747,0.0009348496,0.0003218717,0.00006124969],"category_scores_gemma":[0.0009237359,0.0002015938,0.0006282601,0.0001635636,0.0006812885,0.000006721717,0.0005485963,0.001000158,0.00006497069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004660194,"about_ca_system_score_gemma":0.001513908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.783554e-7,"about_ca_topic_score_gemma":3.113002e-7,"domain_scores_codex":[0.9953577,0.002495651,0.001002279,0.0003172222,0.0004465788,0.0003806062],"domain_scores_gemma":[0.9965002,0.0003185352,0.0009490539,0.001004049,0.00107032,0.0001578525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003840717,0.0007846753,0.000933108,0.3961782,0.01069638,0.003063767,0.00007888313,0.000007525844,0.005084396,0.001625766,0.0556736,0.522033],"study_design_scores_gemma":[0.0003189829,0.0002942763,0.003793387,0.0143538,0.0008872508,0.0001788565,0.00002445261,3.074102e-7,0.00001816169,0.00003456715,0.9798892,0.0002067715],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008252453,0.9902169,7.73154e-7,0.0002715857,0.0001423698,0.0009634258,0.00008732034,0.000001840663,0.00006340722],"genre_scores_gemma":[0.0001721286,0.999137,0.00001210312,0.0002234492,0.0001422816,0.00004882691,0.00003287191,0.00005041182,0.0001808551],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9242156,"threshold_uncertainty_score":0.8220757,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168370388","doi":"10.1056/nejmoa062897","title":"Maintenance Therapy with Certolizumab Pegol for Crohn's Disease","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1048,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Internal medicine; Crohn's disease; Gastroenterology; Tumor necrosis factor alpha; Disease; Adalimumab; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01007076959822188,"gpt":0.2598503375725907,"spread":0.2497795679743688,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002465731,0.0001290784,0.0001635542,0.00005788478,0.00004319452,0.000006193652,0.0001504506,0.00004229202,0.00003544004],"category_scores_gemma":[0.0002290644,0.00007627843,0.00007029295,0.00004061277,0.00009516159,0.000005228057,0.000009765008,0.00008896134,7.465204e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001496853,"about_ca_system_score_gemma":0.000240997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000429948,"about_ca_topic_score_gemma":0.00002818858,"domain_scores_codex":[0.9991352,0.00002708614,0.0002783501,0.0001235732,0.0002151591,0.000220659],"domain_scores_gemma":[0.9988982,0.00003372465,0.0002087943,0.0001740124,0.0002660282,0.0004192253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2757525,0.000458268,0.06279421,0.0002156532,0.0007684281,0.04803405,0.001033194,0.0001800074,0.09053615,0.001164904,0.1036875,0.4153752],"study_design_scores_gemma":[0.1501358,0.003925466,0.3644174,0.0003411696,0.0001840094,0.003782128,0.000220789,0.00002993729,0.004252676,0.0009761064,0.4713345,0.0003999997],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694589,0.001568023,0.02422161,0.003657397,0.0003354712,0.0002427447,0.000006634404,0.000005031605,0.0005042279],"genre_scores_gemma":[0.9935181,0.0002781521,0.0006743735,0.0004271048,0.004393183,0.000002140743,0.00001249196,0.00002154154,0.0006728696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4149752,"threshold_uncertainty_score":0.3110544,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137775651","doi":"10.1136/gut.2006.106781","title":"Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial","year":2007,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1036,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; University of Calgary; University of Alberta","funders":"Cedars-Sinai Medical Center; Abbott Laboratories","keywords":"Adalimumab; Medicine; Crohn's disease; Placebo; Internal medicine; Maintenance therapy; Surgery; Gastroenterology; Clinical trial; Disease; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01364555473206927,"gpt":0.2665932827176399,"spread":0.2529477279855706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001410175,0.00009231981,0.0001031309,0.00001423067,0.00005459746,0.000002258958,0.0001328401,0.00005826707,0.000003463189],"category_scores_gemma":[0.0001961073,0.00006214886,0.0002061759,0.00003128192,0.00009779357,0.000001261206,0.00004247324,0.00001430789,8.271117e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002481413,"about_ca_system_score_gemma":0.0001530091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006810742,"about_ca_topic_score_gemma":0.00005866171,"domain_scores_codex":[0.9992738,0.00002460159,0.0002666886,0.0001726495,0.00009530093,0.0001668937],"domain_scores_gemma":[0.9991874,0.0000158842,0.0002044678,0.0004420979,0.00008583621,0.00006430095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7440511,0.002364162,0.003862597,0.0002231333,0.0004006252,0.0000985411,0.0003962985,0.0001953095,0.208398,0.002404968,0.02381587,0.01378945],"study_design_scores_gemma":[0.1084726,0.002070397,0.5705811,0.00006592803,0.0002214295,0.000001951717,0.00009120063,0.000073145,0.1546914,0.0004479974,0.1629542,0.0003287954],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974563,0.0001664438,0.0002255899,0.0001162148,0.0002491671,0.0006965526,0.0003960264,0.000003942039,0.0006897352],"genre_scores_gemma":[0.9965549,0.00002077752,0.0001007613,0.00004160665,0.0002219962,0.00003894024,0.00005585473,0.00001099412,0.002954145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6355785,"threshold_uncertainty_score":0.2534357,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210258765","doi":"10.1093/ecco-jcc/jjab178","title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","year":2021,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1023,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"National Institute for Health and Care Research; European Crohn's and Colitis Organisation","keywords":"Medicine; Ulcerative colitis; Intensive care medicine; Infliximab; Inflammatory bowel disease; Internal medicine; Gastroenterology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02176821633748907,"gpt":0.3104859880584361,"spread":0.288717771720947,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001791712,0.0001021645,0.0001612954,0.00003248128,0.00003644691,0.0000301102,0.00006275324,0.000102537,0.00008666983],"category_scores_gemma":[0.0001097419,0.00008182463,0.00008458237,0.00003503702,0.00005266437,0.000004303202,0.0000251134,0.00007555126,0.000001731285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003496077,"about_ca_system_score_gemma":0.0005223191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007120424,"about_ca_topic_score_gemma":0.0004047715,"domain_scores_codex":[0.9990903,0.0001065899,0.0003453111,0.0001202382,0.0001955918,0.0001419759],"domain_scores_gemma":[0.9993284,0.00001602517,0.0001024661,0.0001063421,0.0003034931,0.0001433022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0704218,0.004945522,0.07103705,0.0003224532,0.003326399,0.1245115,0.003187233,0.0004774964,0.0083316,0.02547963,0.03665753,0.6513017],"study_design_scores_gemma":[0.002358663,0.0006119393,0.8900458,0.000123339,0.00003911471,0.000518491,0.0003401192,0.00005222944,0.00738306,0.0005058617,0.09787721,0.0001441421],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962345,0.0009695748,0.00003237742,0.001327231,0.0001365865,0.00005911963,0.00002110995,0.00000138002,0.001218126],"genre_scores_gemma":[0.9926282,0.003650411,0.0001930938,0.002365612,0.0004879877,0.000005911588,0.000008931445,0.0000107652,0.0006490669],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8190088,"threshold_uncertainty_score":0.3336712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3022073735","doi":"10.1038/s41572-020-0156-2","title":"Crohn’s disease","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1008,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Wellcome Trust","keywords":"Disease; Medicine; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Gastrointestinal tract; Natural history; Internal medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.01886285803210876,"gpt":0.3250451049030292,"spread":0.3061822468709205,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003400578,0.001298224,0.002057761,0.000138775,0.0001535463,0.00009518045,0.001202073,0.0009024717,0.0002121256],"category_scores_gemma":[0.001451013,0.001069878,0.003171666,0.0003553364,0.0001684677,0.00001096312,0.0005110365,0.00121756,0.001248748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001351551,"about_ca_system_score_gemma":0.002486891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":4.631649e-7,"about_ca_topic_score_gemma":9.97244e-7,"domain_scores_codex":[0.9951808,0.0008488502,0.001118562,0.001700196,0.0004802586,0.0006712654],"domain_scores_gemma":[0.9946473,0.00002495674,0.0007541946,0.001964631,0.0001123196,0.002496663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002381909,0.0001217355,0.0000239863,0.04649631,0.0003888235,0.003464884,0.000003288323,4.710955e-7,0.000001471268,0.0001590834,0.06087746,0.8882243],"study_design_scores_gemma":[0.0002236423,0.00001308104,0.000575254,0.006596193,0.003924812,0.000005942667,9.220893e-7,0.000001523275,3.457406e-7,0.00001871358,0.9875202,0.001119368],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000382292,0.993959,0.00002056159,0.00008563183,0.0006595188,0.003768377,0.0008402764,0.00007898186,0.0005838042],"genre_scores_gemma":[0.000007823272,0.9907882,0.0002030528,0.001549911,0.001627418,0.0009139189,0.003918276,0.0002521364,0.0007392356],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9266427,"threshold_uncertainty_score":0.9999769,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978086188","doi":"10.1002/ibd.21349","title":"Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends","year":2010,"lang":"en","type":"review","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":965,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario; University of Toronto; Hospital for Sick Children; University of Ottawa","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Canadian Child Health Clinician Scientist Program","keywords":"Inflammatory bowel disease; Epidemiology; Medicine; Incidence (geometry); Inflammatory Bowel Diseases; Disease; MEDLINE; Pediatrics; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01829698854668586,"gpt":0.3065966040474354,"spread":0.2882996155007495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001559836,0.001444088,0.003982299,0.0009223201,0.0001126961,0.00001541461,0.002380981,0.000992927,0.0003821976],"category_scores_gemma":[0.006088443,0.001276926,0.003574943,0.0003464082,0.000662377,0.00004318904,0.0007917539,0.0006570214,0.0000992335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001123725,"about_ca_system_score_gemma":0.00230767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001911323,"about_ca_topic_score_gemma":0.000006479353,"domain_scores_codex":[0.9900426,0.001769618,0.005063252,0.001382414,0.0009109462,0.0008312068],"domain_scores_gemma":[0.9893987,0.0004417292,0.00532872,0.003072725,0.00077323,0.0009848601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001588618,0.0002798574,0.02559976,0.9667698,0.001061354,0.0002994886,0.000008925908,0.000006751572,0.000003496562,0.0003795543,0.003175977,0.002256164],"study_design_scores_gemma":[0.001315551,0.0001424151,0.06160115,0.6581867,0.02523801,0.00007922066,0.0000180233,0.00002409411,0.000005431529,0.000105625,0.2502367,0.0030471],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000675498,0.9918751,0.00001508943,0.00002108406,0.001186054,0.00246426,0.003356938,0.0000878733,0.0003181772],"genre_scores_gemma":[0.000184914,0.9923361,0.00007190437,0.000214937,0.001427648,0.001478331,0.003394978,0.0002456233,0.0006455802],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3085831,"threshold_uncertainty_score":0.9998309,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090685459","doi":"10.1053/j.gastro.2003.11.014","title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease","year":2004,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":948,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Infliximab; Medicine; Placebo; Crohn's disease; Inflammatory bowel disease; Internal medicine; Gastroenterology; Surgery; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.0110257074638077,"gpt":0.2809536619036279,"spread":0.2699279544398202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005078961,0.0001267035,0.0002298224,0.00007029911,0.00001356418,0.000004092655,0.00008354599,0.00006163176,0.000006274067],"category_scores_gemma":[0.00001593094,0.0001216717,0.000058752,0.00002457516,0.0002298891,0.000005021058,0.0000570964,0.00003791731,9.983073e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002034509,"about_ca_system_score_gemma":0.000100763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003018849,"about_ca_topic_score_gemma":0.0004742307,"domain_scores_codex":[0.999173,0.00006697119,0.0002991827,0.0002059502,0.00005637001,0.0001985623],"domain_scores_gemma":[0.9995399,0.000003695214,0.0001219977,0.0002186943,0.00003514914,0.00008054841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002348621,0.0004577778,0.9571558,0.00005493793,0.00005162575,0.00006273269,0.0001275395,0.002048729,0.03722015,0.0002758953,0.000003708972,0.0001924943],"study_design_scores_gemma":[0.003510943,0.0007174884,0.987085,0.00001669567,0.0000326837,0.000003976135,0.000224081,0.00004482947,0.008089003,0.0002067028,0.00001847313,0.00005012153],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992186,0.0002184901,0.0002086826,0.00006768489,0.00003347582,0.0001743838,0.00003006925,0.000004066408,0.00004454318],"genre_scores_gemma":[0.9994708,0.00004214797,0.0003481756,0.00003865796,0.00001831839,0.00002587228,0.00004137324,0.000009233444,0.000005361969],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02992921,"threshold_uncertainty_score":0.4961626,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984705525","doi":"10.1053/j.gastro.2013.05.048","title":"Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis","year":2013,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":928,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"UCB Pharma; Genentech; Norgine; Dr. Falk Pharma; Pfizer; Bristol-Myers Squibb","keywords":"Golimumab; Ulcerative colitis; Medicine; Placebo; Internal medicine; Gastroenterology; Clinical endpoint; Vedolizumab; Adverse effect; Clinical trial; Randomization; Tumor necrosis factor alpha; Adalimumab; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.006204841344557701,"gpt":0.2372061494167541,"spread":0.2310013080721964,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000198177,0.0001693023,0.0001943516,0.00006106339,0.00004783187,0.00002287088,0.000114553,0.0001547224,0.00003774725],"category_scores_gemma":[0.0001265289,0.000146809,0.0000301969,0.00003146825,0.0001207628,0.000008771363,0.0001351414,0.0001363937,0.00002156733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002312482,"about_ca_system_score_gemma":0.00005406854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001329201,"about_ca_topic_score_gemma":0.0001985324,"domain_scores_codex":[0.9982721,0.0005575448,0.0002861158,0.0004383798,0.00009030395,0.0003555209],"domain_scores_gemma":[0.9992996,0.00002290645,0.00007556376,0.0002512523,0.000121707,0.000228931],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09484857,0.000157516,0.9016036,0.000007063152,0.00003519646,0.0001037877,0.0000805384,0.0000639948,0.001713721,0.00000268998,0.000849445,0.0005338207],"study_design_scores_gemma":[0.003531652,0.003157878,0.9928413,0.000015427,0.000007316932,0.00003542112,0.00003405122,0.00003670833,0.0001102058,0.00002008356,0.0001034952,0.0001064282],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990238,0.000003803078,0.00004544254,0.0002838426,0.00006451762,0.0004997261,0.00002592337,0.000009254803,0.00004370992],"genre_scores_gemma":[0.9981562,0.000005588647,0.0003501657,0.001218664,0.00004375668,0.00006003681,0.00004977764,0.00002060238,0.00009515195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09131692,"threshold_uncertainty_score":0.5986698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}